Synaptogenix (SNPX) Competitors

$4.57
+0.21 (+4.82%)
(As of 04/23/2024 ET)

SNPX vs. DRUG, GTBP, CPHI, SONN, SNGX, PXMD, KA, SEEL, PTPI, and ALZN

Should you be buying Synaptogenix stock or one of its competitors? The main competitors of Synaptogenix include Bright Minds Biosciences (DRUG), GT Biopharma (GTBP), China Pharma (CPHI), Sonnet BioTherapeutics (SONN), Soligenix (SNGX), PaxMedica (PXMD), Kineta (KA), Seelos Therapeutics (SEEL), Petros Pharmaceuticals (PTPI), and Alzamend Neuro (ALZN). These companies are all part of the "pharmaceutical preparations" industry.

Synaptogenix vs.

Synaptogenix (NASDAQ:SNPX) and Bright Minds Biosciences (NASDAQ:DRUG) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, media sentiment, community ranking, institutional ownership, dividends, profitability and earnings.

Synaptogenix has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500. Comparatively, Bright Minds Biosciences has a beta of 1.42, suggesting that its stock price is 42% more volatile than the S&P 500.

Bright Minds Biosciences is trading at a lower price-to-earnings ratio than Synaptogenix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SynaptogenixN/AN/A-$6.04M-$26.25-0.17
Bright Minds BiosciencesN/AN/A-$5.47M-$1.31-0.85

10.3% of Synaptogenix shares are held by institutional investors. Comparatively, 40.5% of Bright Minds Biosciences shares are held by institutional investors. 4.3% of Synaptogenix shares are held by company insiders. Comparatively, 42.7% of Bright Minds Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Synaptogenix's average media sentiment score of 0.00 equaled Bright Minds Biosciences'average media sentiment score.

Company Overall Sentiment
Synaptogenix Neutral
Bright Minds Biosciences Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Synaptogenix
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Bright Minds Biosciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Synaptogenix's return on equity of -22.50% beat Bright Minds Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
SynaptogenixN/A -22.50% -18.10%
Bright Minds Biosciences N/A -91.83%-83.54%

Synaptogenix received 1 more outperform votes than Bright Minds Biosciences when rated by MarketBeat users.

CompanyUnderperformOutperform
SynaptogenixOutperform Votes
1
50.00%
Underperform Votes
1
50.00%
Bright Minds BiosciencesN/AN/A

Summary

Bright Minds Biosciences beats Synaptogenix on 5 of the 9 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNPX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNPX vs. The Competition

MetricSynaptogenixPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$4.98M$6.49B$4.83B$7.49B
Dividend YieldN/A3.10%5.47%3.98%
P/E Ratio-0.1717.47262.0320.92
Price / SalesN/A314.822,530.9384.97
Price / CashN/A19.2531.9427.25
Price / Book0.185.624.674.31
Net Income-$6.04M$138.18M$102.38M$213.83M
7 Day Performance-1.72%-1.25%-0.32%0.70%
1 Month Performance-2.30%-8.53%-5.76%-4.06%
1 Year Performance-81.15%0.44%9.79%6.42%

Synaptogenix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DRUG
Bright Minds Biosciences
0 of 5 stars
$1.14
-7.3%
N/A-61.3%$5.05MN/A-0.87N/AGap Up
GTBP
GT Biopharma
0.9858 of 5 stars
$3.70
-2.6%
$150.00
+3,954.1%
-70.5%$5.11MN/A-0.412
CPHI
China Pharma
0 of 5 stars
$0.35
-2.8%
N/A-81.4%$5.11M$7.01M0.00234Gap Up
High Trading Volume
SONN
Sonnet BioTherapeutics
0.7158 of 5 stars
$1.67
-7.7%
$88.70
+5,211.4%
-67.6%$5.13M$129,176.000.0012
SNGX
Soligenix
0.4414 of 5 stars
$0.47
flat
$3.00
+535.6%
-73.7%$4.97M$840,000.00-0.5213Gap Down
High Trading Volume
PXMD
PaxMedica
2.4797 of 5 stars
$0.66
-10.8%
$3.00
+354.5%
-97.4%$4.89MN/A-0.036
KA
Kineta
2.8615 of 5 stars
$0.48
+41.2%
$8.00
+1,567.7%
-83.3%$5.26M$5.44M-0.3511Gap Up
High Trading Volume
SEEL
Seelos Therapeutics
1.8833 of 5 stars
$0.39
-11.5%
$70.00
+18,077.1%
-98.4%$5.27M$2.20M0.0015Positive News
PTPI
Petros Pharmaceuticals
2.1224 of 5 stars
$0.71
-10.2%
$4.00
+467.4%
-87.2%$4.85M$5.82M-0.1124News Coverage
Gap Up
ALZN
Alzamend Neuro
0.6329 of 5 stars
$0.78
+5.4%
N/A-91.9%$5.36MN/A-0.794Positive News

Related Companies and Tools

This page (NASDAQ:SNPX) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners